86 related articles for article (PubMed ID: 23376365)
1. Focus.
Friedman SL
J Hepatol; 2013 May; 58(5):845-6. PubMed ID: 23376365
[No Abstract] [Full Text] [Related]
2. Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice.
Lin CW; Zhang H; Li M; Xiong X; Chen X; Chen X; Dong XC; Yin XM
J Hepatol; 2013 May; 58(5):993-9. PubMed ID: 23339953
[TBL] [Abstract][Full Text] [Related]
3. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice.
You M; Considine RV; Leone TC; Kelly DP; Crabb DW
Hepatology; 2005 Sep; 42(3):568-77. PubMed ID: 16108051
[TBL] [Abstract][Full Text] [Related]
4. [A brief report on the third national congress of fatty liver disease and summit forum of Hong Kong, Taiwan and mainland China].
Wang BY; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):73-4. PubMed ID: 20128980
[No Abstract] [Full Text] [Related]
5. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
Qin R; Zhang J; Li C; Zhang X; Xiong A; Huang F; Yin Z; Li K; Qin W; Chen M; Zhang S; Liang L; Zhang H; Nie H; Ye W
Arch Pharm Res; 2012 Jul; 35(7):1241-50. PubMed ID: 22864747
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cytochrome P4502E1 by chlormethiazole attenuated acute ethanol-induced fatty liver.
Chen YY; Zhang CL; Zhao XL; Xie KQ; Zeng T
Chem Biol Interact; 2014 Oct; 222():18-26. PubMed ID: 25162931
[TBL] [Abstract][Full Text] [Related]
7. Alcoholic liver disease: Mucosal microbes exacerbate experimental alcoholic steatohepatitis.
Ray K
Nat Rev Gastroenterol Hepatol; 2016 Mar; 13(3):121. PubMed ID: 26882878
[No Abstract] [Full Text] [Related]
8. Statins and non-alcoholic steatohepatitis.
Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
J Hepatol; 2016 Jan; 64(1):241-2. PubMed ID: 26456845
[No Abstract] [Full Text] [Related]
9. Reply to "Statin treatment for non-alcoholic steatohepatitis".
Dongiovanni P; Pihlajamaki J; Romeo S; Valenti L
J Hepatol; 2016 Jan; 64(1):242-3. PubMed ID: 26456843
[No Abstract] [Full Text] [Related]
10. [Steatosis and non-alcoholic steatohepatitis].
Marín-López ER; Marín-Rentería NM
Rev Gastroenterol Mex; 2013 Aug; 78 Suppl 1():96-7. PubMed ID: 24041073
[No Abstract] [Full Text] [Related]
11. Do we need a histological score to diagnose non-alcoholic steatohepatitis?
Wong VW; Chan HL
Aliment Pharmacol Ther; 2011 Aug; 34(4):494-5; author reply 495-6. PubMed ID: 21767281
[No Abstract] [Full Text] [Related]
12. Altered intestinal microbiota as a major driving force in alcoholic steatohepatitis.
Tilg H; Mathurin P
Gut; 2016 May; 65(5):728-9. PubMed ID: 26786686
[No Abstract] [Full Text] [Related]
13. Adiponectin and alcoholic fatty liver: Is it, after all, about what you eat?
Anania FA
Hepatology; 2005 Sep; 42(3):530-2. PubMed ID: 16116627
[No Abstract] [Full Text] [Related]
14. Towards prevention of alcoholic liver disease.
Lancet; 1978 Aug; 2(8085):353-4. PubMed ID: 79715
[No Abstract] [Full Text] [Related]
15. Resveratrol Ameliorates Alcoholic Fatty Liver by Inducing Autophagy.
Tang L; Yang F; Fang Z; Hu C
Am J Chin Med; 2016; 44(6):1207-1220. PubMed ID: 27627919
[TBL] [Abstract][Full Text] [Related]
16. Kupffer cells activation promoted binge drinking-induced fatty liver by activating lipolysis in white adipose tissues.
Zhao YY; Yang R; Xiao M; Guan MJ; Zhao N; Zeng T
Toxicology; 2017 Sep; 390():53-60. PubMed ID: 28882574
[TBL] [Abstract][Full Text] [Related]
17. Alcoholic fatty liver is enhanced in CYP2A5 knockout mice: The role of the PPARα-FGF21 axis.
Chen X; Ward SC; Cederbaum AI; Xiong H; Lu Y
Toxicology; 2017 Mar; 379():12-21. PubMed ID: 28131861
[TBL] [Abstract][Full Text] [Related]
18. [Autophagy and nonalcoholic fatty liver disease].
Li XQ; Wang W; Jia YH; Zhao CY
Zhonghua Gan Zang Bing Za Zhi; 2016 Aug; 24(8):632-635. PubMed ID: 27788715
[TBL] [Abstract][Full Text] [Related]
19. [Non-alcoholic fatty liver disease (NAFLD) /non-alcoholic steatohepatitis (NASH) and nutrition].
Ishii KA; Takamura T
Clin Calcium; 2016 Mar; 26(3):363-7. PubMed ID: 26923972
[TBL] [Abstract][Full Text] [Related]
20. Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro.
Mahli A; Thasler WE; Patsenker E; Müller S; Stickel F; Müller M; Seitz HK; Cederbaum AI; Hellerbrand C
Oncotarget; 2015 Dec; 6(39):41464-78. PubMed ID: 26497211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
